Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10 » The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
Please verify you are not a robot.
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10 » The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
Please verify you are not a robot.